Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Director | December 31, 2010 | January 04, 2011 |
| BOEING COBA · Entity 2862 | Director | January 03, 2011 | January 04, 2011 |
| Bank of New York Mellon CorpBK · Entity 2899 | Vice Chairman | July 18, 2019 | July 22, 2019 |
| WELLS FARGO & COMPANY/MNWFC · Entity 2824 | Vice Chairman - Public Affairs | March 05, 2024 | March 08, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date December 31, 2010 · Filed January 04, 2011
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 12,760 |
Reported balance
After 2010-12-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2010-12-31 · Grant · Acquired 594 · Balance 12,760 F1: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. |
Filing footnotes · ownership attribution and instrument terms
F1: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.
F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.
BOEING CO
Report date January 03, 2011 · Filed January 04, 2011
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 16,444.16 |
Reported balance
After 2011-01-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2011-01-03 · Grant · Acquired 942.12 · Balance 16,444.16 F1: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2: Phantom stock units awarded or acquired in lieu of director cash compensation. F3: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F4: Includes adjustments for dividends accrued. |
Filing footnotes · ownership attribution and instrument terms
F1: Phantom stock units are convertible into common stock on a 1-for-1 basis.
F2: Phantom stock units awarded or acquired in lieu of director cash compensation.
F3: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director.
F4: Includes adjustments for dividends accrued.
Bank of New York Mellon Corp
Report date July 18, 2019 · Filed July 22, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,700 |
Reported balance
After 2019-07-18 transaction · row 1
1 source rowRow 1 · 2019-07-18 · Purchase · Acquired 5,700 · Balance 5,700 F1: Represents the weighted average price of shares sold with actual prices ranging from 44.89 to 44.94. Upon request by the SEC staff, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within this range. |
| Common StockSEC Table I · non-derivative | IndirectBy IRA | 5,650 |
Reported balance
After 2019-07-18 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2019-07-18 · Purchase · Acquired 5,650 · Balance 5,650 F2: Represents the weighted average price of shares sold with actual prices ranging from 44.87 to 44.97. Upon request by the SEC staff, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within this range. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the weighted average price of shares sold with actual prices ranging from 44.89 to 44.94. Upon request by the SEC staff, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within this range.
F2: Represents the weighted average price of shares sold with actual prices ranging from 44.87 to 44.97. Upon request by the SEC staff, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within this range.
WELLS FARGO & COMPANY/MN
Report date March 05, 2024 · Filed March 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $1 2/3 Par ValueSEC Table I · non-derivative | Direct | 51,364.1951 |
Ending reported balance
After 2024-03-05 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-03-05 · Exercise / conversion · Acquired 63,050.7777 · Balance 83,501.4523 F1: These shares represent common stock of Wells Fargo & Company (the "Company") acquired on March 5, 2024 upon settlement of a Performance Share award granted on January 26, 2021 for the three-year performance period ended December 31, 2023 (as previously disclosed on a Form 4 filed on February 29, 2024), plus dividend equivalents invested in additional Performance Shares. Row 2 · 2024-03-05 · Tax withholding · Disposed 32,137.2572 · Balance 51,364.1951 |
| 2021 Performance SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-03-05 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-03-05 · Exercise / conversion · Disposed 63,050.7777 · Balance 0 F2: Each Performance Share represents a contingent right to receive one share of Company common stock upon vesting. F3: Represents the number of 2021 Performance Shares determined based on financial performance for the three-year performance period ended December 31, 2023 pursuant to the terms and conditions of a Performance Share award granted on January 26, 2021, plus dividend equivalents invested in additional Performance Shares, which is exempt under Rule 16b-3(d). As a condition to receiving the grant, the reporting person agreed to hold, while employed by the Company and for one year after retirement, shares of Company common stock as required under the Company's Stock Ownership Policy. |
| Common Stock, $1 2/3 Par ValueSEC Table I · non-derivative | IndirectThrough IRA | 5,600 |
Reported balance
Holding disclosure · report date 2024-03-05 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 5,600 |
| Common Stock, $1 2/3 Par ValueSEC Table I · non-derivative | IndirectThrough Trust | 46,912 |
Reported balance
Holding disclosure · report date 2024-03-05 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 46,912 |
Filing footnotes · ownership attribution and instrument terms
F1: These shares represent common stock of Wells Fargo & Company (the "Company") acquired on March 5, 2024 upon settlement of a Performance Share award granted on January 26, 2021 for the three-year performance period ended December 31, 2023 (as previously disclosed on a Form 4 filed on February 29, 2024), plus dividend equivalents invested in additional Performance Shares.
F2: Each Performance Share represents a contingent right to receive one share of Company common stock upon vesting.
F3: Represents the number of 2021 Performance Shares determined based on financial performance for the three-year performance period ended December 31, 2023 pursuant to the terms and conditions of a Performance Share award granted on January 26, 2021, plus dividend equivalents invested in additional Performance Shares, which is exempt under Rule 16b-3(d). As a condition to receiving the grant, the reporting person agreed to hold, while employed by the Company and for one year after retirement, shares of Company common stock as required under the Company's Stock Ownership Policy.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AT&T INC.
Report date May 15, 2004 · Filed May 18, 2004
Section 16 reporting ended · disclosed 2004-05-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,983 |
Reported balance
After 2004-05-15 transaction · row 1
1 source rowRow 1 · 2004-05-15 · Disposition to issuer · Disposed 23,300 · Balance 13,983 F1: Reporting person resigned on May 15, 2004, and as a result, forfeited 23,300 shares of restricted stock and company matching cont ributions under company benefit plans. |
| Common StockSEC Table I · non-derivative | IndirectBy benefit plans | 28,349.91 |
Reported balance
After 2004-05-15 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2004-05-15 · Disposition to issuer · Disposed 2,375.677 · Balance 28,349.91 F1: Reporting person resigned on May 15, 2004, and as a result, forfeited 23,300 shares of restricted stock and company matching cont ributions under company benefit plans. |
| Common StockSEC Table I · non-derivative | Indirectby 401(k) | 1,448.967 |
Reported balance
Holding disclosure · report date 2004-05-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,448.967 |
Filing footnotes · ownership attribution and instrument terms
F1: Reporting person resigned on May 15, 2004, and as a result, forfeited 23,300 shares of restricted stock and company matching cont ributions under company benefit plans.
JPMORGAN CHASE & CO
Report date January 06, 2011 · Filed January 10, 2011
Section 16 reporting ended · disclosed 2011-01-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 175,678 |
Ending reported balance
After 2011-01-06 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2011-01-06 · Exercise / conversion · Acquired 100,000 · Balance 214,414 Row 2 · 2011-01-06 · Exercise / conversion · Acquired 59,662 · Balance 274,076 F1: Each restricted stock unit represents a contingent right to receive one share of JPMC common stock. Row 3 · 2011-01-06 · Exercise / conversion · Acquired 42,251 · Balance 316,327 F1: Each restricted stock unit represents a contingent right to receive one share of JPMC common stock. Row 4 · 2011-01-06 · Tax withholding · Disposed 140,649 · Balance 175,678 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2013-01-13 | Direct | 0 |
Reported balance
After 2011-01-06 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2011-01-06 · Exercise / conversion · Disposed 42,251 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of JPMC common stock. F2: Restricted stock unit vested on January 6, 2011. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2012-01-25 | Direct | 0 |
Reported balance
After 2011-01-06 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2011-01-06 · Exercise / conversion · Disposed 59,662 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of JPMC common stock. F2: Restricted stock unit vested on January 6, 2011. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $34.78 · Expires 2015-10-20 | Direct | 0 |
Reported balance
After 2011-01-06 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2011-01-06 · Exercise / conversion · Disposed 100,000 · Balance 0 F3: Stock Appreciation Right became exercisable on January 6, 2011. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of JPMC common stock.
F2: Restricted stock unit vested on January 6, 2011.
F3: Stock Appreciation Right became exercisable on January 6, 2011.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2020 Filed Mar 3, 2020 19:08 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | PurchaseCommon Stock, $1 2/3 Par Value | 5,600 | $40.99 | $229,544.00 |
DisclosureSEC source: 0001127602-20-008837 · form4.xml · nonDerivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Vice Chairman - Public Affairs 10b5-1 filing: Not disclosed Ownership: Indirect · Through IRA Disclosed balance after: 5,600 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40.95 to $41.06 inclusive. The reporting person undertakes to provide to Wells Fargo & Company (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| November 19, 2019 Filed Nov 21, 2019 19:15 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantRestricted Share Right · Derivative | 23,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-033473 · form4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Vice Chairman - Public Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,136 Underlying: Common Stock, $1 2/3 Par Value · 23,136 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Right ("RSR") represents a contingent right to receive one share of Wells Fargo & Company (the "Company") common stock. F2 · derivative.exercise_date: These RSRs vest in three installments: one-third on 12/15/2020, 12/15/2021, and 12/15/2022. As a condition to receiving the grant, the reporting person agreed to hold, while employed by the Company and for at least one year after retirement, shares of Company common stock equal to at least 50% of the after-tax shares (assuming a 50% tax rate) acquired upon vesting. F2 · derivative.expiration_date: These RSRs vest in three installments: one-third on 12/15/2020, 12/15/2021, and 12/15/2022. As a condition to receiving the grant, the reporting person agreed to hold, while employed by the Company and for at least one year after retirement, shares of Company common stock equal to at least 50% of the after-tax shares (assuming a 50% tax rate) acquired upon vesting. Read SEC document |
| July 18, 2019 Filed Jul 22, 2019 16:34 UTC | Bank of New York Mellon Corp BK · Entity 2899 | PurchaseCommon Stock | 5,650 | $44.93 | $253,827.95 |
DisclosureSEC source: 0001209191-19-042884 · doc4.xml · nonDerivative · entry 2 DALEY WILLIAM M · CIK 0001183865 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 5,650 F2 · price: Represents the weighted average price of shares sold with actual prices ranging from 44.87 to 44.97. Upon request by the SEC staff, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| July 18, 2019 Filed Jul 22, 2019 16:34 UTC | Bank of New York Mellon Corp BK · Entity 2899 | PurchaseCommon Stock | 5,700 | $44.93 | $256,093.02 |
DisclosureSEC source: 0001209191-19-042884 · doc4.xml · nonDerivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,700 F1 · price: Represents the weighted average price of shares sold with actual prices ranging from 44.89 to 44.94. Upon request by the SEC staff, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| January 06, 2011 Filed Jan 10, 2011 17:16 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Exercise / conversionStock Appreciation Rights · Derivative | 100,000 | $0.00 Strike: $34.78 | $0.00 |
DisclosureSEC source: 0001225208-11-001943 · doc4.xml · derivative · entry 7 DALEY WILLIAM M · CIK 0001183865 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2015-10-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock Appreciation Right became exercisable on January 6, 2011. Read SEC document |
| January 06, 2011 Filed Jan 10, 2011 17:16 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Exercise / conversionRestricted Stock Units · Derivative | 59,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-001943 · doc4.xml · derivative · entry 6 DALEY WILLIAM M · CIK 0001183865 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 59,662 shares Expires 2012-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of JPMC common stock. F2 · derivative.exercise_date: Restricted stock unit vested on January 6, 2011. Read SEC document |
| January 06, 2011 Filed Jan 10, 2011 17:16 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Exercise / conversionRestricted Stock Units · Derivative | 42,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-001943 · doc4.xml · derivative · entry 5 DALEY WILLIAM M · CIK 0001183865 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,251 shares Expires 2013-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of JPMC common stock. F2 · derivative.exercise_date: Restricted stock unit vested on January 6, 2011. Read SEC document |
| January 06, 2011 Filed Jan 10, 2011 17:16 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Tax withholdingCommon Stock | 140,649 | $44.53 | $6,262,396.73 |
DisclosureSEC source: 0001225208-11-001943 · doc4.xml · nonDerivative · entry 4 DALEY WILLIAM M · CIK 0001183865 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,678 Read SEC document |
| January 06, 2011 Filed Jan 10, 2011 17:16 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Exercise / conversionCommon Stock | 42,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-001943 · doc4.xml · nonDerivative · entry 3 DALEY WILLIAM M · CIK 0001183865 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,327 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of JPMC common stock. Read SEC document |
| January 06, 2011 Filed Jan 10, 2011 17:16 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Exercise / conversionCommon Stock | 59,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-001943 · doc4.xml · nonDerivative · entry 2 DALEY WILLIAM M · CIK 0001183865 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of JPMC common stock. Read SEC document |
| January 06, 2011 Filed Jan 10, 2011 17:16 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Exercise / conversionCommon Stock | 100,000 | $34.78 | $3,478,000.00 |
DisclosureSEC source: 0001225208-11-001943 · doc4.xml · nonDerivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2011 Filed Jan 4, 2011 22:26 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 942.12 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-000717 · doc4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,444.16 Underlying: Common Stock · 942.12 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| December 31, 2010 Filed Jan 4, 2011 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 594 | $47.91 Strike: $0.00 | $28,458.54 |
DisclosureSEC source: 0001179110-11-000337 · edgar.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,760 Underlying: Common shares · 594 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| October 01, 2010 Filed Oct 5, 2010 21:07 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 482.73 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-022278 · doc4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,404.48 Underlying: Common Stock · 482.73 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| September 30, 2010 Filed Oct 1, 2010 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 545 | $52.24 Strike: $0.00 | $28,470.80 |
DisclosureSEC source: 0001179110-10-014512 · edgar.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,055 Underlying: Common shares · 545 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| July 01, 2010 Filed Jul 6, 2010 18:57 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 524.07 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-016694 · doc4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,825.59 Underlying: Common Stock · 524.07 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| June 30, 2010 Filed Jul 2, 2010 21:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 609 | $46.78 Strike: $0.00 | $28,489.02 |
DisclosureSEC source: 0001179110-10-011349 · edgar.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,409 Underlying: Common shares · 609 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| April 23, 2010 Filed Apr 27, 2010 22:22 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 2,108 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-007455 · edgar.xml · nonDerivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,736 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 16, 2010 Filed Apr 19, 2010 11:36 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | GiftCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-010514 · doc4.xml · nonDerivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,414 Read SEC document |
| April 01, 2010 Filed Apr 5, 2010 22:30 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 445.79 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-009892 · doc4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,205.55 Underlying: Common Stock · 445.79 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| March 31, 2010 Filed Apr 2, 2010 21:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 541 | $52.68 Strike: $0.00 | $28,499.88 |
DisclosureSEC source: 0001179110-10-006462 · edgar.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,702 Underlying: Common shares · 541 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| February 03, 2010 Filed Feb 5, 2010 08:44 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | GrantStock Appreciation Rights · Derivative | 100,000 | $0.00 Strike: $43.20 | $0.00 |
DisclosureSEC source: 0001225208-10-003572 · doc4.xml · derivative · entry 2 DALEY WILLIAM M · CIK 0001183865 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2020-01-20 F2 · kind: See Exhibit 99.1 for description of the Firm's bonus recovery policies applicable to these awards. F4 · derivative.exercise_date: Stock appreciation rights, which have a ten-year term, become exercisable in five equal installments beginning January 20, 2011. Shares resulting from exercise must be held at least five years from the grant date. Read SEC document |
| February 03, 2010 Filed Feb 5, 2010 08:44 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | GrantRestricted Stock Units · Derivative | 42,251 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-003572 · doc4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,251 Underlying: Common Stock · 42,251 shares Expires 2013-01-13 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of JPMC common stock. F2 · kind: See Exhibit 99.1 for description of the Firm's bonus recovery policies applicable to these awards. F3 · derivative.exercise_date: Restricted stock units vest 50% on January 13, 2012 and 50% on January 13, 2013. Read SEC document |
| January 25, 2010 Filed Jan 27, 2010 16:57 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Tax withholdingCommon Stock | 15,178 | $39.37 | $597,485.01 |
DisclosureSEC source: 0001225208-10-002379 · doc4.xml · nonDerivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,414 Read SEC document |
| January 04, 2010 Filed Jan 6, 2010 21:40 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 584.58 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-000979 · doc4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,674.09 Underlying: Common Stock · 584.58 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| December 31, 2009 Filed Jan 5, 2010 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 527 | $53.99 Strike: $0.00 | $28,452.73 |
DisclosureSEC source: 0001179110-10-000395 · edgar.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,087 Underlying: Common shares · 527 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| October 01, 2009 Filed Oct 5, 2009 18:53 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 1,085.62 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-020154 · doc4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,989.47 Underlying: Common Stock · 1,085.62 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| September 30, 2009 Filed Oct 2, 2009 20:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 576 | $49.47 Strike: $0.00 | $28,494.72 |
DisclosureSEC source: 0001179110-09-014047 · edgar.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,487 Underlying: Common Shares · 576 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| July 01, 2009 Filed Jul 6, 2009 21:06 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 1,351.35 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-015352 · doc4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,801.97 Underlying: Common Stock · 1,351.35 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| June 30, 2009 Filed Jul 1, 2009 21:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 573 | $47.04 Strike: $0.00 | $26,953.92 |
DisclosureSEC source: 0001179110-09-010345 · edgar.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,831 Underlying: Common Shares · 573 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| April 24, 2009 Filed Apr 28, 2009 22:22 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 2,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-09-026804 · a4.xml · nonDerivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,628 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 19:56 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 1,647.33 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-009858 · doc4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,368.01 Underlying: Common Stock · 1,647.33 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| March 31, 2009 Filed Apr 2, 2009 23:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 503 | $47.70 Strike: $0.00 | $23,993.10 |
DisclosureSEC source: 0001104659-09-022376 · a4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,182 Underlying: Common Shares · 503 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| January 25, 2009 Filed Jan 27, 2009 13:58 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Tax withholdingCommon Stock | 6,353 | $23.20 | $147,357.84 |
DisclosureSEC source: 0001225208-09-002031 · doc4.xml · nonDerivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,592 Read SEC document |
| January 20, 2009 Filed Jan 22, 2009 20:35 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | GrantStock Appreciation Rights · Derivative | 100,000 | $0.00 Strike: $19.49 | $0.00 |
DisclosureSEC source: 0001225208-09-001850 · doc4.xml · derivative · entry 2 DALEY WILLIAM M · CIK 0001183865 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2019-01-20 F3 · derivative.exercise_date: Stock Appreciation Rights, which have a ten-year term, become exercisable in five equal annual installments beginning January 20, 2010. Shares resulting from exercise must be held at least 5 years from the grant date. Read SEC document |
| January 20, 2009 Filed Jan 22, 2009 20:35 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | GrantRestricted Stock Units · Derivative | 59,662 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-001850 · doc4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,662 Underlying: Common Stock · 59,662 shares Expires 2012-01-25 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of JPMC common stock. F2 · derivative.exercise_date: Restricted stock units vest 50% on January 25, 2011 and 50% on January 25, 2012. Read SEC document |
| January 02, 2009 Filed Jan 6, 2009 21:44 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 1,301.79 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-000791 · doc4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,599.46 Underlying: Common Stock · 1,301.79 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| December 31, 2008 Filed Jan 5, 2009 22:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 449 | $53.37 Strike: $0.00 | $23,963.13 |
DisclosureSEC source: 0001104659-09-000343 · a4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,629 Underlying: Common shares · 449 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| October 01, 2008 Filed Oct 3, 2008 22:29 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 904.12 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-08-015850 · doc4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,221.5 Underlying: Common Stock · 904.12 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| September 30, 2008 Filed Oct 2, 2008 21:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 416 | $57.58 Strike: $0.00 | $23,953.28 |
DisclosureSEC source: 0001104659-08-061714 · a4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,132 Underlying: Common shares · 416 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| July 01, 2008 Filed Jul 3, 2008 17:20 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 783.76 | $0.00 | $0.00 |
DisclosureSEC source: 0001137638-08-000067 · dal1885.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,277.33 Underlying: Common · 783.76 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| June 30, 2008 Filed Jul 2, 2008 23:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 453 | $52.97 Strike: $0.00 | $23,995.41 |
DisclosureSEC source: 0001104659-08-043859 · a4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,675 Underlying: Common shares · 453 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| April 25, 2008 Filed Apr 30, 2008 00:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 1,917 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-08-028089 · a4.xml · nonDerivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,163 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 01, 2008 Filed Apr 3, 2008 21:43 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 680.2 | $0.00 | $0.00 |
DisclosureSEC source: 0001137638-08-000049 · dal1849.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,464.34 Underlying: Common · 680.2 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| March 31, 2008 Filed Apr 2, 2008 22:29 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 435 | $55.15 Strike: $0.00 | $23,990.25 |
DisclosureSEC source: 0001104659-08-022151 · a4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,181 Underlying: Common shares · 435 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| January 22, 2008 Filed Jan 22, 2008 21:05 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | GrantStock Appreciation Rights · Derivative | 150,000 | $0.00 Strike: $39.83 | $0.00 |
DisclosureSEC source: 0001225208-08-001425 · doc4.xml · derivative · entry 2 DALEY WILLIAM M · CIK 0001183865 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2018-01-22 F2 · derivative.exercise_date: SARs vest and become exercisable in five equal annual installments beginning January 22, 2009. Shares resulting from exercise must be held at least until 5 years after the grant. Read SEC document |
| January 22, 2008 Filed Jan 22, 2008 21:05 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | GrantCommon Stock | 54,294 | $39.83 | $2,162,530.02 |
DisclosureSEC source: 0001225208-08-001425 · doc4.xml · nonDerivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,945 F1 · kind: Award of restricted stock units vests 50% on January 25, 2010 and 50% on January 25, 2011. Read SEC document |
| January 02, 2008 Filed Jan 4, 2008 19:05 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 589.62 | $0.00 | $0.00 |
DisclosureSEC source: 0001137638-08-000005 · dal1790.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,759.63 Underlying: Common · 589.62 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| December 31, 2007 Filed Jan 2, 2008 23:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 427 | $56.15 Strike: $0.00 | $23,976.05 |
DisclosureSEC source: 0001104659-08-000234 · a4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,713 Underlying: Common shares · 427 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| October 01, 2007 Filed Oct 3, 2007 21:50 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 482.99 | $0.00 | $0.00 |
DisclosureSEC source: 0001137638-07-000166 · dal1782.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,154.35 Underlying: Common · 482.99 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.